• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Economy

Hims Stock Soared 8.87% Last Week: Should You Invest?

by July 31, 2024
written by July 31, 2024

Hims Stock Soared By 8.87% Last Week. Should You Buy?

Making good investment decisions is paramount for achieving success in the financial markets. Some stocks seem like fine opportunities, but ultimately, they prove to be wrong choices. On the other hand, others aren’t so lauded, but they bring hefty profits to the traders. Which category does the Hims Stock belong to? What is its potential for growth? And should you purchase these shares now or not?

Hims & Hers Health, Inc., the company behind this stock, provides healthcare platforms. People seeking to improve their health and wellness often use its website for its numerous advantages.

The company enables customers to get access to a provider network. It also offers a cloud pharmacy, an electronic medical record system, and digital prescriptions. Additionally, people can receive treatment for various conditions, such as acne, hair loss, sexual health concerns, and mental health issues, as well as support for weight loss.

The Hims & Hers platform serves as an intermediary between patients and licensed healthcare professionals, who can prescribe medications if needed. Customers can also purchase various healthcare and wellness products on the website.

Additionally, the Hims & Hers mobile application provides users with access to educational programs and various other healthcare-related services.

The platform has a vast and growing community of users, which translates to substantial income from fees and sales. As a result, the stock price has been soaring for the past several months.

How Is Hims Faring Now?

The Hims stock has experienced occasional fluctuations but has traded mainly in bullish territory. Moreover, its market capitalisation recently reached almost $4.66 billion. The company’s revenue hit $959.40 million, according to the latest reports. These figures, along with the shares’ upward trajectory, have bolstered the popularity of Hims & Hers stock in the market.

The shares exchanged hands at $21.71 on Monday, declining slightly during the last session. However, over the last quarter, the company experienced substantial insider buying. This indicates that the individuals who know the inner workings of the firm have faith in it and expect further growth.

The stock price experienced high volatility. At one point, it even plunged by 64.5% compared to its estimated fair value. However, some analysts believe that its revenue will grow exponentially in the coming months and years.

What Is The Hims Stock Forecast?

Some of the top analysts forecast Hims’ earnings to grow by 40.32% per year. Moreover, they think the revenue will increase by 18.5% in the same period of time.

Analyst recommendations are based on technical analysis, earnings reports, average returns, and market factors. When they suggest Hims & Hers stock could outperform the US market average, there’s a real possibility. The company is also expanding its products and platform while improving leadership to ensure smooth operations.

As a result, this stock currently has a buy rating, attracting many traders. However, despite this positive news, some experts believe Hims’ trajectory may change soon. Last week, its price soared by 8.57% before starting to trade in the red on Monday.

If Everything’s Alright, Why Is Hims Stock Going Down?

Analysts warn that Hims is currently overvalued due to the long bull run. So, the price might decrease in the coming months, especially if investor interest wanes.

On Tuesday, Glen Santangelo of Jefferies downgraded his recommendation for these shares. He previously ranked the stock a buy but has now moved his rating to hold. Moreover, he cut his price target from $17 to $15.

According to Santangelo, Hims & Hers showed solid performance, but it’s overvalued now. He advises investors to wait until the shares’ price decreases and buy the stock after that.

Still, other analysts predict that the stock price will increase over the next decade. For 2030, they estimate that Hims value will reach $33.10, but only if the stock continues growing with its current 10-year average growth rate.

On the other hand, it’s still possible and even expected that the stock will lose some of its overpriced winnings before it continues growing at a more adequate rate. So, investors should follow the stock market news and Hims’ developments and wait until its price drops before buying it.

The post Hims Stock Soared 8.87% Last Week: Should You Invest? appeared first on FinanceBrokerage.

0 comment
0
FacebookTwitterPinterestEmail

previous post
Delaware Republican running for governor aims to flip one-party rule in Biden’s home state after three decades
next post
EURUSD and GBPUSD: The Euro could rise to the 1.08500 level

related articles

Oil Prices Rebound After Trump’s Criticism of Powell

April 22, 2025

Trump’s Fed Criticism Sparks Investor Concerns

April 22, 2025

Buy Bitcoin Under $100K Before The Next Bull...

April 22, 2025

BNB Price Surge Leads Crypto Gains as Bitcoin...

April 21, 2025

Fed’s Stagflation Warning Impacts Crypto Markets

April 21, 2025

Bitcoin Slips to $83.6K Amid Nvidia’s $5.5B Charge

April 21, 2025

Gold Price Surge Hits $3,385 Amid Trade Tensions

April 21, 2025

Bitcoin Rebounds to $83,404 Amid Renewed Investor Confidence

April 21, 2025

Memecoins, AI, and DeFi Tokens Lead Crypto Rebound

April 21, 2025

Bitcoin Nears $85K Amid Market Optimism

April 21, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • PETA protests Biden turkey pardon with ‘Hell on Wheels’ display, subliminal messaging to make people go vegan

    November 25, 2024
  • ‘Let us be the parents’: Supreme Court should let parents opt kids out of LGBTQ school lessons, lawyer argues

    April 22, 2025
  • Hezbollah fires barrage of rockets into Israel after IDF targets Hezbollah command centers in Beirut

    November 25, 2024
  • Biden saying ‘Don’t’ and other threats seemingly fail to deter Iran as more US Mideast bases hit

    August 11, 2024
  • Republican state AGs await Trump-brokered TikTok deal, remain skeptical on app safety

    January 27, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 3

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 4

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (4,735)
  • Investing (624)
  • Stock (775)

Latest Posts

  • Left-wing dark money network hauled in more than $1.3B in anonymous donations for liberal causes in 2023

    November 16, 2024
  • Top Russian official lands in Iran amid US, UK concerns over alleged nuclear deal

    September 17, 2024
  • Retiring Corvette ‘godfather’ on EVs, spinoff and a performance SUV

    August 6, 2024

Recent Posts

  • Graham says Israel has window to ‘replace Hamas forever’ after Sinwar killing: ‘Door is now open’

    October 20, 2024
  • Johnson touts GOP unity over record-breaking fundraising numbers ahead of RNC

    July 13, 2024
  • Ethereum continues to hold above weekly support at $3250

    July 31, 2024

Editor’s Pick

  • I wanted an abortion. But then I made a friend who saved my baby

    November 24, 2024
  • Blame game intensifies in Congress as government shutdown threat inches closer

    March 1, 2025
  • Wayfair CEO likens home goods slowdown to 2008 financial crisis

    August 2, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock